Mp Swathi Karanth1, Nilkanth Tukaram Awad2. 1. Senior Resident, Department of Pulmonary Medicine, Lokamanya Tilak Municipal Medical College and LTMGH, Mumbai, Maharashtra, India. 2. Professor and Head of Department, Department of Pulmonary Medicine, Lokamanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.
Abstract
INTRODUCTION: Six Minute Walk Test (6MWT) is a simple test used to measure exercise capacity in Chronic Pulmonary Diseases (CPDs). Decreased exercise capacity significantly affects the quality of life. The 6MWT is a known tool to measure exercise capacity and quality of life in CPD. However, the role of change in follow up Six Minute Walk Distance (6MWD) in assessing mortality and its correlation with known prognostic factors haven't been tested to the best of our knowledge. AIM: To study the correlation of change in 6MWD with change in spirometry and to study the role of 6MWD in predicting mortality in CPD. SETTINGS AND DESIGN: Prospective cohort study. MATERIALS AND METHODS: A total of 139 CPD patients were grouped into obstructive, restrictive and post Tuberculosis (TB) sequelae. Optimized treatment was given and they were followed up regularly. Spirometry and 6MWT was done at the beginning and after one year. Mean decline in FEV1, FVC was correlated with mean decline in 6MWD. STATISTICAL ANALYSIS: With STATA 13.1 correlation between 6MWT and spirometric values were done using Wilcoxon signed rank test. Predictors of mortality were studied using multivariate analysis. RESULTS: Overall mean decline in 6MWD was 16.07 m/year. There was no correlation between mean change in 6MWD and change in FEV1, FVC, and FEV1/FVC. On multivariate analysis, 6MWD was the better predictor of mortality than FEV1 (p<0.001), FVC (p<0.001). At cut off value of 240 meters, sensitivity and specificity of 6MWT in predicting mortality was 71.05% and 81.94% respectively. CONCLUSION: The 6MWD changes independently and has no correlation with change in spirometry, it is an independent predictor of mortality in CPD.
INTRODUCTION: Six Minute Walk Test (6MWT) is a simple test used to measure exercise capacity in Chronic Pulmonary Diseases (CPDs). Decreased exercise capacity significantly affects the quality of life. The 6MWT is a known tool to measure exercise capacity and quality of life in CPD. However, the role of change in follow up Six Minute Walk Distance (6MWD) in assessing mortality and its correlation with known prognostic factors haven't been tested to the best of our knowledge. AIM: To study the correlation of change in 6MWD with change in spirometry and to study the role of 6MWD in predicting mortality in CPD. SETTINGS AND DESIGN: Prospective cohort study. MATERIALS AND METHODS: A total of 139 CPDpatients were grouped into obstructive, restrictive and post Tuberculosis (TB) sequelae. Optimized treatment was given and they were followed up regularly. Spirometry and 6MWT was done at the beginning and after one year. Mean decline in FEV1, FVC was correlated with mean decline in 6MWD. STATISTICAL ANALYSIS: With STATA 13.1 correlation between 6MWT and spirometric values were done using Wilcoxon signed rank test. Predictors of mortality were studied using multivariate analysis. RESULTS: Overall mean decline in 6MWD was 16.07 m/year. There was no correlation between mean change in 6MWD and change in FEV1, FVC, and FEV1/FVC. On multivariate analysis, 6MWD was the better predictor of mortality than FEV1 (p<0.001), FVC (p<0.001). At cut off value of 240 meters, sensitivity and specificity of 6MWT in predicting mortality was 71.05% and 81.94% respectively. CONCLUSION: The 6MWD changes independently and has no correlation with change in spirometry, it is an independent predictor of mortality in CPD.
Entities:
Keywords:
Lung diseases; Six minute walk distance; Spirometry
Authors: Harry R Gosker; Mariëlle P K J Engelen; Henk van Mameren; Paul J van Dijk; Ger J van der Vusse; Emiel F M Wouters; Annemie M W J Schols Journal: Am J Clin Nutr Date: 2002-07 Impact factor: 7.045
Authors: Henrik Watz; Benjamin Waschki; Corinna Boehme; Martin Claussen; Thorsten Meyer; Helgo Magnussen Journal: Am J Respir Crit Care Med Date: 2007-11-29 Impact factor: 21.405
Authors: Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos Journal: NPJ Prim Care Respir Med Date: 2021-05-07 Impact factor: 2.871
Authors: B W Allwood; M Stolbrink; N Baines; E Louw; D T Wademan; A Lupton-Smith; S Nel; D Maree; S Mpagama; M Osman; F M Marx; G Hoddinott; M Lesosky; J Rylance; K Mortimer Journal: Int J Tuberc Lung Dis Date: 2021-04-01 Impact factor: 2.373
Authors: Rebekah A Blakney; Emily E Ricotta; Dean Follmann; Jessica Drew; Kelly A Carey; Lisa N Glass; Chevalia Robinson; Sandra MacDonald; Pamela J McShane; Kenneth N Olivier; Kevin Fennelly; D Rebecca Prevots Journal: BMC Infect Dis Date: 2022-01-21 Impact factor: 3.090